These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12972087

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Validated stability-indicating HPLC-UV method for simultaneous determination of glipizide and four impurities.
    Gupta S, Bansal G.
    J AOAC Int; 2011; 94(2):523-30. PubMed ID: 21563686
    [Abstract] [Full Text] [Related]

  • 25. Determination of azithromycin by ion-pair HPLC with UV detection.
    Yang ZY, Wang L, Tang X.
    J Pharm Biomed Anal; 2009 Apr 05; 49(3):811-5. PubMed ID: 19162426
    [Abstract] [Full Text] [Related]

  • 26. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG, Karmuse PP, Ghugare PD, Gupta M, Nerurkar B, Shaha C, Kumar A.
    J Pharm Biomed Anal; 2007 Jan 04; 43(1):186-95. PubMed ID: 16916594
    [Abstract] [Full Text] [Related]

  • 27. Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.
    Patel HU, Suhagia BN, Patel CN.
    J AOAC Int; 2010 Jan 04; 93(6):1862-7. PubMed ID: 21313813
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L, Wlasichuk KB, Schmidt DE, Campbell RL, Hirtzer P, Cheng L, Karr DE.
    J Pharm Biomed Anal; 2012 Jul 04; 66():75-84. PubMed ID: 22459505
    [Abstract] [Full Text] [Related]

  • 30. Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
    Zhou H, Tai Y, Sun C, Pan Y.
    J Pharm Biomed Anal; 2005 Feb 07; 37(1):97-107. PubMed ID: 15664748
    [Abstract] [Full Text] [Related]

  • 31. Development and validation of a non-aqueous reversed-phase high-performance liquid chromatographic method for the determination of four chemical UV filters in suncare formulations.
    Smyrniotakis CG, Archontaki HA.
    J Chromatogr A; 2004 Mar 26; 1031(1-2):319-24. PubMed ID: 15058600
    [Abstract] [Full Text] [Related]

  • 32. Development and validation of column high-performance liquid chromatographic and derivative spectrophotometric methods for determination of levofloxacin and ornidazole in combined dosage forms.
    Patel SA, Prajapati AM, Patel PU, Patel NJ, Vaghmasi JB.
    J AOAC Int; 2008 Mar 26; 91(4):756-61. PubMed ID: 18727534
    [Abstract] [Full Text] [Related]

  • 33. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
    Wu CS, Tong YF, Wang PY, Wang DM, Wu S, Zhang JL.
    Rapid Commun Mass Spectrom; 2013 May 15; 27(9):971-8. PubMed ID: 23592199
    [Abstract] [Full Text] [Related]

  • 34. A stability-indicating method for the determination of melphalan and related impurity content by gradient HPLC.
    Brightman K, Finlay G, Jarvis I, Knowlton T, Manktelow CT.
    J Pharm Biomed Anal; 1999 Jul 15; 20(3):439-47. PubMed ID: 10701960
    [Abstract] [Full Text] [Related]

  • 35. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D, Basniwal PK.
    J Pharm Biomed Anal; 2013 Dec 15; 86():11-35. PubMed ID: 23969330
    [Abstract] [Full Text] [Related]

  • 36. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N, Sangeetha D, Reddy SP.
    J Chromatogr Sci; 2012 Oct 15; 50(9):810-9. PubMed ID: 22661461
    [Abstract] [Full Text] [Related]

  • 37. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).
    Liu M, Wang J, Liu P.
    J Pharm Biomed Anal; 2016 Nov 30; 131():429-435. PubMed ID: 27661436
    [Abstract] [Full Text] [Related]

  • 38. Validation of a HPLC method for the quantification and purity determination of SK3530 in drug substance and tablet.
    Oh JG, Jang WJ, Chi SC.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):1179-84. PubMed ID: 17134866
    [Abstract] [Full Text] [Related]

  • 39. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
    Ammari WG, Al-Qadhi Z, Khalil M, Tayyem R, Qammaz S, Oriquat G, Basheti IA, Chrystyn H.
    J Aerosol Med Pulm Drug Deliv; 2015 Jun 19; 28(3):202-10. PubMed ID: 25229261
    [Abstract] [Full Text] [Related]

  • 40. Comprehensive impurity profiling of nutritional infusion solutions by multidimensional off-line reversed-phase liquid chromatography × hydrophilic interaction chromatography-ion trap mass-spectrometry and charged aerosol detection with universal calibration.
    Schiesel S, Lämmerhofer M, Lindner W.
    J Chromatogr A; 2012 Oct 12; 1259():100-10. PubMed ID: 22284534
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.